Academic Content and Language Evaluation of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6125)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Feb 16, 2022 (publication date) through Nov 3, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Zhu WJ, Da YW, Chen H, Xu M, Lu Y, Di L, Duo JY. Tacrolimus treatment for relapsing-remitting chronic inflammatory demyelinating polyradiculoneuropathy: Two case reports . World J Clin Cases 2022; 10(5): 1709-1715 [PMID: 35211613 DOI: 10.12998/wjcc.v10.i5.1709] |
|
|
|
| ©2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Zhu WJ, Da YW, Chen H, Xu M, Lu Y, Di L, Duo JY. Tacrolimus treatment for relapsing-remitting chronic inflammatory demyelinating polyradiculoneuropathy: Two case reports . World J Clin Cases 2022; 10(5): 1709-1715 [PMID: 35211613 DOI: 10.12998/wjcc.v10.i5.1709] |
|---|---|
| URL: | https://www.wjgnet.com/2220-3230/full/v10/i5/1709.htm |
| Number | Citing Articles |
| 1 |
Meng-ge Yang, Li Xu, Suqiong Ji, Huajie Gao, Qing Zhang, Bitao Bu. Tacrolimus Combined with Corticosteroids Improved the Outcome of CIDP Patients with Autoantibodies Against Paranodal Proteins. Neuropsychiatric Disease and Treatment 2022; : 1207 doi: 10.2147/NDT.S361461
|
| 2 |
Li Di, Xinmei Wen, Wenjia Zhu, Min Wang, Yan Lu, Min Xu, Hai Chen, Yuwei Da. Efficacy of Tacrolimus Plus Prednisone as Long-Term Immunosuppressive Therapy for Chronic Inflammatory Demyelinating Polyneuropathy: A Retrospective Cohort Study. ImmunoTargets and Therapy 2025; : 1133 doi: 10.2147/ITT.S536989
|
| 3 |
|